Gryphon Investors Acquires RoC Skincare from Johnson & Johnson
January 22, 2019
Gryphon Investors, a San Francisco-based private equity firm, acquired RoC Skincare from Johnson & Johnson Consumer Inc. The carve-out positions RoC as a standalone consumer skincare platform with Gryphon planning to expand the product portfolio, strengthen international support, and deepen dermatologist and retail partnerships.
- Buyers
- Gryphon Investors
- Targets
- RoC Skincare
- Sellers
- Johnson & Johnson Consumer Inc.
- Industry
- Consumer Products
- Location
- New York, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Bridgepoint Acquires RoC Skincare from Gryphon Investors
February 29, 2024
Consumer Products
Bridgepoint Europe VII has acquired RoC Skincare from Gryphon Investors; financial terms were not disclosed. The investment will leverage Bridgepoint’s European presence and sector expertise to accelerate RoC’s growth across Europe and internationally, expand its product offering, and strengthen its online and retail channels.
-
KKR Makes Minority Investment in SkinSpirit
October 20, 2022
Healthcare Services
KKR has made a minority growth investment in SkinSpirit, a U.S. medical‑aesthetics and medical‑spa platform, to accelerate national expansion and talent development while founder Lynn Heublein remains in leadership. GreyLion, an earlier investor, will remain a minority owner as KKR invests through its Health Care Strategic Growth Fund II to support scaling the business.
-
Gryphon Investors Acquires Revision Skincare and Goodier Cosmetics (Revision Goodier)
November 8, 2021
Consumer Products
Gryphon Investors has signed a definitive agreement to acquire Revision Skincare and Goodier Cosmetics (collectively "Revision Goodier") from RoundTable Healthcare Partners; financial terms were not disclosed. Gryphon said it will partner with CEO Maria Carell and the existing management team to expand Revision's global footprint and advance Goodier's CDMO capabilities; the transaction, announced in November 2021, closed in late 2021.
-
Blackstone Tactical Opportunities Acquires Majority Stake in ZO Skin Health
October 5, 2020
Consumer Products
Funds managed by Blackstone Tactical Opportunities have acquired a majority stake in ZO Skin Health, the Irvine, California–based physician-dispensed skincare brand founded by Dr. Zein Obagi. The investment will provide ZO with additional resources to support global growth; financial terms were not disclosed.
-
Crown Laboratories Acquires Xycrobe Therapeutics, Inc.
May 22, 2019
Biotechnology
Crown Laboratories, a privately held skin care company based in Johnson City, Tennessee, has acquired Xycrobe Therapeutics, a developer of skin microbiome-based biotherapeutic technology. Crown plans to integrate Xycrobe’s microbiome platform and scientific team into its R&D organization to expand therapeutic and consumer skin-care capabilities; financial terms were not disclosed.
-
Crown Laboratories Acquires Keri Brand from GlaxoSmithKline
May 1, 2019
Consumer Products
Crown Laboratories acquired the North American rights to the Keri skin care brand from GlaxoSmithKline and concurrently received an equity investment from Greenspring Associates. Existing investors Hildred Capital Partners and Montreux Equity Partners provided financing in connection with the transaction; financial terms were not disclosed.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.